Cytokines production of U5A2‐13‐positive T cells by stimulation with glycolipid α‐galactosylceramide

M. Azuma,K. Kato,Y. Ikarashi,R. Asada‐Mikami,H. Maruoka,Y. Takaue,A. Saito,H. Wakasugi
DOI: https://doi.org/10.1002/1521-4141(2000)30:8<2138::AID-IMMU2138>3.0.CO;2-Y
2000-07-01
European Journal of Immunology
Abstract:We have previously established and reported a novel monoclonal antibody (mAb), U5A2‐13, which recognizes a phenotypically similar population of natural killer (NK)‐like T cells. Using U5A2‐13 mAb, we now describe the functional properties of U5A2‐13+ T cells in both NK1.1‐positive or ‐negative mouse strains. Similar to NK1.1+ T cells, hepatic U5A2‐13+ T cells of C57BL/6 (NK1.1+ strain) mice, but not U5A2‐13– T cells, could be induced to produce large amounts of IL‐4 and IFN‐γ by stimulation with glycolipid α‐galactosylceramide (α‐GalCer) present on dendritic cells (DC) in a dose‐dependent manner. The abundant production of these cytokines from U5A2‐13+ T cells of BALB/c (NK1.1– strain) mice is similar to that noted in C57BL/6 mice. Cytokine production by cultures stimulated with DC of β2‐microglobulin‐deficient mice was significantly less than that of cultures stimulated with DC of intact mice. Overall, U5A2‐13+ T cells recognize α‐GalCer presented by CD1d, indicating that U5A2‐13+ T cells can be used to analyze NK‐like T cell function in various strains of mice.
What problem does this paper attempt to address?